<p>Quibim, a Spanish startup that&#8217;s developing foundational AI models for medical imaging spanning oncology, immunology, neurology, and metabolic disorders, has raised $50 million in a Series A round of funding. The cash injection comes as AI makes ever deeper inroads into healthcare, spanning everything from drug discovery to clinical trials. Quibim, for its part, is [&hellip;]</p>

<p>LinkedIn founder Reid Hoffman and Siddhartha Mukherjee, cancer researcher and author of the book “The Emperor of All Maladies,” have co-founded an AI-powered drug discovery startup, Manas AI. The company, which will initially focus on breast cancer, prostate cancer, and lymphoma, has raised $24.6 million in seed funding from Hoffman, General Catalyst, and Greylock. Manas [&hellip;]</p>

<p>Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT reports.</p>

<p>Growing up with an OB-GYN father, Rachel Blank assumed that most women received excellent gynecological care. She regularly witnessed her dad’s patients thanking him for delivering their child when they would bump into him around town. But Blank realized that not all women’s health issues are treated equally when, at the age of 21, she was [&hellip;]</p>

<p>Stockholm startup Neko Health has made a big bet on consumers wanting to learn about their state of health and how to prevent things going wrong. Now investors are making a big bet on Neko.  The startup has raised a fresh $260 million in funding, a Series B that values Neko at $1.8 billion post-money, [&hellip;]</p>

<p>The dream of battery-free devices has taken an unlikely turn, as Carnegie Mellon researchers debuted Power-Over-Skin. The technology allows for electrical currents to travel through human skin in a bid to power things like blood sugar monitors, pacemakers, and even consumer wearables like smart glasses and fitness trackers. Researchers note the tech is still in [&hellip;]</p>

<p>Alongside a slew of announcements tied to Samsung’s Galaxy S25 launch at Samsung Unpacked 2025 on Wednesday, Google announced a pair of accessibility improvements for Android. This includes improvements to the screen reader, along with hearing aid functionality. The hearing aid updates arrive after Google expanded the offering as part of its Android 15 rollout. [&hellip;]</p>

<p>A four-year-old London startup backed by Peter Thiel has raised a $55 million Series B round as it sets about &#8220;fixing the broken clinical trial industry.&#8221; The announcement comes as artificial intelligence is shaping up to revolutionize drug discovery and development, in turn spurring demand for a streamlined clinical trial process to help get new [&hellip;]</p>

<p>A four-year-old London startup backed by Peter Thiel has raised a $55 million Series B round as it sets about &#8220;fixing the broken clinical trial industry.&#8221; The announcement comes as artificial intelligence is shaping up to revolutionize drug discovery and development, in turn spurring demand for a streamlined clinical trial process to help get new [&hellip;]</p>

<p>OpenAI says it trained a new AI model called GPT-4b micro with Retro Biosciences, a longevity science startup trying to extend the human lifespan by 10 years, according to the MIT Technology Review. Retro, which is backed by Sam Altman, has been working with OpenAI for roughly a year on this research, according to the [&hellip;]</p>

<p>You can’t start a company without a healthy dose of daring, and that’s certainly the case with NeuroBionics. The MIT-spinout thinks it could one day improve the lives of millions of people who live with neurological conditions like depression, epilepsy, and Parkinson&#8217;s disease.&nbsp; Famed investor Steve Jurvetson of Future Ventures says that if everything goes [&hellip;]</p>

<p>You can’t start a company without a healthy dose of daring, and that’s certainly the case with NeuroBionics. The MIT-spinout thinks it could one day improve the lives of millions of people who live with neurological conditions like depression, epilepsy, and Parkinson&#8217;s disease.&nbsp; Famed investor Steve Jurvetson of Future Ventures says that if everything goes [&hellip;]</p>

<p>The process of getting screened for cervical cancer is quite intimidating. It’s the once-a-year, sometimes life-changing treatment that involves the bright lights of a doctor’s office and an uncomfortable insertion that always seems to last too long.   It’s no wonder Kara Egan and Dr. Avnesh Thakor saw the potential to make this process more comfortable [&hellip;]</p>

<p>The process of getting screened for cervical cancer is quite intimidating. It’s the once-a-year, sometimes life-changing treatment that involves the bright lights of a doctor’s office and an uncomfortable insertion that always seems to last too long.   It’s no wonder Kara Egan and Dr. Avnesh Thakor saw the potential to make this process more comfortable [&hellip;]</p>

<p>Colossal Biosciences wants to bring back the woolly mammoth and has raised $200 million at a $10.2 billion valuation to do it.</p>

<p>Colossal Biosciences wants to bring back the woolly mammoth and has raised $200 million at a $10.2 billion valuation to do it.</p>

<p>A fledgling French AI startup has raised $41 million to develop a foundational AI model for biology. Just as OpenAI&#8217;s ChatGPT has taken the world by storm as a super-smart generative AI tool capable of natural language conversation in text form, Bioptimus is taking that concept but training its model specifically for downstream biological applications [&hellip;]</p>

<p>Healthcare is proving to be one of the more lucrative industries for building AI solutions to speed up clinical, research, and administrative operations. Now, we have one of the latest examples of how that is playing out in terms of venture funding. Qventus, a startup that builds AI-based tools to automate work across a range [&hellip;]</p>

<p>Healthcare is proving to be one of the more lucrative industries for building AI solutions to speed up clinical, research, and administrative operations. Now, we have one of the latest examples of how that is playing out in terms of venture funding. Qventus, a startup that builds AI-based tools to automate work across a range [&hellip;]</p>

<p>Around the world, public healthcare systems have struggled to reset post-pandemic, and in particular, the increasingly aged populations in Western countries are putting pressure on services, not least in the U.K. where &#8220;NHS in crisis&#8221; is a regular headline in the media. As a result, private companies, many powered with technology, see a gap in [&hellip;]</p>